We conclude that FBXW7-mutant cells from multiple cancer types are more sensitive to ATR inhibition, which is broadly applicable to several cancer types, revealing a druggable synthetic lethal interaction between DNA repair genes and FBXW7 mutations. The gene discussed is ATR; the disease is cancer.